Morrison Foerster advised Celadon Partners and GeneFab, while Cooley and Goodwin Procter advised Senti Biosciences. Senti Biosciences, Inc. (Nasdaq: SNTI) and Celadon Partners, LLC announced a transaction...
Celadon Partners’ $38 Million Acquisition of Senti Bio’s Assets
ACELYRIN’s $621 Million Initial Public Offering
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
AstraZeneca’s Acquisition of Neogene Therapeutics
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...
Hazel’s Merger Agreements with Even and ONE
Wachtell, Lipton, Rosen and Katz represented Even in the transaction. Hazel, the independent fintech launched in partnership with Walmart and fintech investment firm Ribbit Capital, has...
BYJU’S’ $500 Million Acquisition of Epic
Wilson Sonsini Goodrich & Rosati advised Epic on the deal while Cooley LLP represented Byju’s. The global leader in personalized online learning, BYJU’s (backed by General...